Visiopharm
Visiopharm is a privately-owned company founded in 2002, operating internationally with over 750 customer accounts in more than 40 countries. They are a leading provider of AI-driven precision pathology software for both research and diagnostics. In research, their software aids scientists, pathologists, and image analysis experts in generating accurate data for tissue-based research. For diagnostics, Visiopharm offers IVDR-cleared algorithms that provide decision support and integrate into existing lab workflows. Their solutions are built on 20 years of knowledge combined with AI, ensuring accuracy and versatility for tissue analysis challenges. Visiopharm's commitment to scientific advancement is reflected in their solutions being featured in over 3,300 scientific publications, and they hold EN ISO 13485:2016 certification.
Visiopharm
Visiopharm is a privately-owned company founded in 2002, operating internationally with over 750 customer accounts in more than 40 countries. They are a leading provider of AI-driven precision pathology software for both research and diagnostics. In research, their software aids scientists, pathologists, and image analysis experts in generating accurate data for tissue-based research. For diagnostics, Visiopharm offers IVDR-cleared algorithms that provide decision support and integrate into existing lab workflows. Their solutions are built on 20 years of knowledge combined with AI, ensuring accuracy and versatility for tissue analysis challenges. Visiopharm's commitment to scientific advancement is reflected in their solutions being featured in over 3,300 scientific publications, and they hold EN ISO 13485:2016 certification.